This information was published on 2025-10-17T10:16:08 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2593169 (IR 1879394) |
| (220) |
10 Sep 2025
|
| (300) |
US, 10 Mar 2025, 99075149
|
| (511) (510) |
Class 5
Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of bone diseases and disorders; pharmaceutical preparations and substances for the treatment of pathological calcification; pharmaceutical preparations and substances for the treatment of blood plasma pyrophosphate deficiency disorders; pharmaceutical preparations and substances for the treatment of kidney diseases and disorders. |
| (540) | ENLANPPI |
| (550) | Word |
| (730) |
Inozyme Pharma, Inc.
|
Find out more about publications on the About page.